240 related articles for article (PubMed ID: 10630956)
21. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
22. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunoassay for the detection of HBeAg and anti-HBe.
Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B
Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390
[TBL] [Abstract][Full Text] [Related]
24. Cross-Reactivity of HBe Antigen-Specific Polyclonal Antibody with HBc Antigen.
Hojatizadeh M; Amiri MM; Mobini M; Hassanzadeh Makoui M; Ghaedi M; Ghotloo S; Peyghami K; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
Viral Immunol; 2023; 36(6):378-388. PubMed ID: 37294935
[TBL] [Abstract][Full Text] [Related]
25. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
[TBL] [Abstract][Full Text] [Related]
26. [Sensitivity and specificity of 4 domestic ELISA kits for detection of hepatitis B virus markers].
Wu X; Zhou C; Huang WJ; Qi ZB; Liang ZL; Li HM; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Sep; 29(9):915-8. PubMed ID: 19173858
[TBL] [Abstract][Full Text] [Related]
27. Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen.
Kantelhardt VC; Schwarz A; Wend U; Schüttler CG; Willems WR; Trimoulet P; Fleury H; Gerlich WH; Kann M
J Clin Virol; 2009 Oct; 46(2):124-8. PubMed ID: 19631583
[TBL] [Abstract][Full Text] [Related]
28. Relative functional affinity of specific anti-core IgG in different categories of hepatitis B virus infection.
Thomas HI
J Med Virol; 1997 Mar; 51(3):189-97. PubMed ID: 9139082
[TBL] [Abstract][Full Text] [Related]
29. [Localization of the N-terminal epitope of the HBe antigen of the hepatitis B virus].
Karpenko LI; Riazankin IA; Chikaev NA; Seregin SV; Il'ichev AA; Petrenko VA
Mol Gen Mikrobiol Virusol; 1993; (3):29-31. PubMed ID: 7688854
[TBL] [Abstract][Full Text] [Related]
30. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
32. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers.
Yap SF; Wong NW; Goh KL
Malays J Pathol; 1994 Jun; 16(1):57-62. PubMed ID: 16329577
[TBL] [Abstract][Full Text] [Related]
33. Development of enzyme-linked immunosorbent assay for hepatitis B e antigen.
Petchclai B; Niemhom S
J Med Assoc Thai; 1990 Mar; 73(3):124-9. PubMed ID: 2380643
[TBL] [Abstract][Full Text] [Related]
34. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.
Jung MC; Diepolder HM; Spengler U; Wierenga EA; Zachoval R; Hoffmann RM; Eichenlaub D; Frösner G; Will H; Pape GR
J Virol; 1995 Jun; 69(6):3358-68. PubMed ID: 7538172
[TBL] [Abstract][Full Text] [Related]
35. Comparison of class and subclass distribution of antibodies to the hepatitis B core and B e antigens in chronic hepatitis B.
Sällberg M; Norder H; Magnius LO
J Med Virol; 1990 Jan; 30(1):1-6. PubMed ID: 2303802
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
Hsu YS; Chien RN; Yeh CT; Sheen IS; Chiou HY; Chu CM; Liaw YF
Hepatology; 2002 Jun; 35(6):1522-7. PubMed ID: 12029639
[TBL] [Abstract][Full Text] [Related]
37. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
Han Y; Tang Q; Zhu W; Zhang X; You L
J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
[TBL] [Abstract][Full Text] [Related]
38. Low frequency of precore mutants in anti-hepatitis B e antigen positive subjects with chronic hepatitis B virus infection in Chennai, Southern India.
Shanmugam S; Velu V; Nandakumar S; Madhavan V; Shanmugasundaram U; Shankar EM; Murugavel KG; Balakrishnan P; Kumarasamy N; Solomon S; Thyagarajan SP
J Microbiol Biotechnol; 2008 Oct; 18(10):1722-8. PubMed ID: 18955826
[TBL] [Abstract][Full Text] [Related]
39. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
[TBL] [Abstract][Full Text] [Related]
40. Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
Li ZX; Hong GQ; Hu B; Liang MJ; Xu J; Li L
Protein Expr Purif; 2007 Dec; 56(2):293-300. PubMed ID: 17897838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
